FibroBiologics (FBLG) Competitors $0.64 +0.03 (+4.72%) As of 01:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBLG vs. WHWK, OCX, VIRI, CRBP, ADAG, ENTX, ORMP, JMAC, IVVD, and EXOZShould you be buying FibroBiologics stock or one of its competitors? The main competitors of FibroBiologics include Whitehawk Therapeutics (WHWK), OncoCyte (OCX), Virios Therapeutics (VIRI), Corbus Pharmaceuticals (CRBP), Adagene (ADAG), Entera Bio (ENTX), Oramed Pharmaceuticals (ORMP), Maxpro Capital Acquisition (JMAC), Invivyd (IVVD), and eXoZymes (EXOZ). These companies are all part of the "pharmaceutical products" industry. FibroBiologics vs. Its Competitors Whitehawk Therapeutics OncoCyte Virios Therapeutics Corbus Pharmaceuticals Adagene Entera Bio Oramed Pharmaceuticals Maxpro Capital Acquisition Invivyd eXoZymes Whitehawk Therapeutics (NASDAQ:WHWK) and FibroBiologics (NASDAQ:FBLG) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends. Which has stronger valuation and earnings, WHWK or FBLG? FibroBiologics has lower revenue, but higher earnings than Whitehawk Therapeutics. FibroBiologics is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWhitehawk Therapeutics$25.98M3.61-$63.69M$0.1612.44FibroBiologicsN/AN/A-$11.16M-$0.21-2.93 Do institutionals and insiders have more ownership in WHWK or FBLG? 52.1% of Whitehawk Therapeutics shares are owned by institutional investors. 49.9% of Whitehawk Therapeutics shares are owned by insiders. Comparatively, 20.0% of FibroBiologics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, WHWK or FBLG? Whitehawk Therapeutics has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.78, meaning that its stock price is 178% less volatile than the S&P 500. Is WHWK or FBLG more profitable? Whitehawk Therapeutics has a net margin of 99.42% compared to FibroBiologics' net margin of 0.00%. Whitehawk Therapeutics' return on equity of -56.73% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets Whitehawk Therapeutics99.42% -56.73% -48.68% FibroBiologics N/A -1,022.04%-117.56% Does the media refer more to WHWK or FBLG? In the previous week, FibroBiologics' average media sentiment score of 1.89 beat Whitehawk Therapeutics' score of 0.00 indicating that FibroBiologics is being referred to more favorably in the news media. Company Overall Sentiment Whitehawk Therapeutics Neutral FibroBiologics Very Positive Do analysts rate WHWK or FBLG? FibroBiologics has a consensus target price of $13.00, indicating a potential upside of 2,010.39%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts plainly believe FibroBiologics is more favorable than Whitehawk Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Whitehawk Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 SummaryWhitehawk Therapeutics beats FibroBiologics on 9 of the 15 factors compared between the two stocks. Get FibroBiologics News Delivered to You Automatically Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBLG vs. The Competition Export to ExcelMetricFibroBiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.61M$2.90B$5.50B$9.03BDividend YieldN/A2.64%5.39%4.11%P/E Ratio-2.9421.4127.5220.10Price / SalesN/A279.21397.84108.06Price / CashN/A41.4736.1356.90Price / Book7.707.457.985.65Net Income-$11.16M-$55.05M$3.16B$248.47M7 Day Performance-13.48%2.83%1.91%2.80%1 Month Performance-21.88%5.56%4.17%5.62%1 Year Performance-85.44%6.39%35.76%21.20% FibroBiologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBLGFibroBiologics3.0741 of 5 stars$0.64+4.7%$13.00+1,934.4%-85.3%$24.45MN/A-3.0410Positive NewsGap UpWHWKWhitehawk TherapeuticsN/A$1.87-3.1%N/AN/A$90.92M$25.98M0.0040OCXOncoCyte2.804 of 5 stars$3.18+16.3%$6.06+90.9%+7.3%$90.80M$3.84M-0.90120VIRIVirios TherapeuticsN/A$4.71-1.3%$5.00+6.2%+2,015.4%$90.71MN/A-17.445CRBPCorbus Pharmaceuticals3.9189 of 5 stars$6.90-6.8%$50.88+637.3%-83.9%$90.55MN/A-1.6440Negative NewsADAGAdagene2.0094 of 5 stars$1.95+1.6%$8.00+310.3%-35.1%$90.45M$100K0.00260ENTXEntera Bio2.8359 of 5 stars$1.90-4.0%$10.00+426.3%+11.7%$89.99M$180K-7.3120Positive NewsGap UpORMPOramed Pharmaceuticals0.5732 of 5 stars$2.25+4.7%N/A-16.1%$87.83M$2M-5.1110News CoverageGap DownJMACMaxpro Capital AcquisitionN/A$6.51+1.5%N/A+2,947.6%$87.42MN/A0.002,021Gap DownIVVDInvivyd3.2841 of 5 stars$0.72-1.6%$5.85+718.2%-34.3%$87.15M$25.38M-0.60100News CoverageGap UpEXOZeXoZymesN/A$9.88-4.9%N/AN/A$86.94MN/A0.0029News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies WHWK Competitors OCX Competitors VIRI Competitors CRBP Competitors ADAG Competitors ENTX Competitors ORMP Competitors JMAC Competitors IVVD Competitors EXOZ Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBLG) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
